Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancerSatoru Shintani, Hiroyuki Hamakawa|International Journal of Cancer|2003Cited by 95
P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-Allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell linesSatoru Shintani, Hiroyuki Hamakawa|International Journal of Oncology|2006Cited by 35